These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 2040794)

  • 21. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells.
    Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC
    Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab')2-co-stimulated B lymphocytes.
    Schliephake DE; Schimpl A
    Eur J Immunol; 1996 Jan; 26(1):268-71. PubMed ID: 8566078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation.
    Hamano T; Asofsky R
    J Immunol; 1983 May; 130(5):2027-32. PubMed ID: 6403617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells.
    Kwekkeboom J; De Boer M; Tager JM; De Groot C
    Immunology; 1993 Jul; 79(3):439-44. PubMed ID: 7691726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.
    Pezzutto A; Dörken B; Rabinovitch PS; Ledbetter JA; Moldenhauer G; Clark EA
    J Immunol; 1987 May; 138(9):2793-9. PubMed ID: 2437199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-linking of surface IgM, but not surface IgD receptors, by soluble monoclonal antibodies primes murine B cells to secrete immunoglobulin in response to lymphokines.
    Phillips C; Klaus GG
    Eur J Immunol; 1993 Feb; 23(2):574-7. PubMed ID: 8436190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.
    Gruber MF; Bjorndahl JM; Nakamura S; Fu SM
    J Immunol; 1989 Jun; 142(12):4144-52. PubMed ID: 2470814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo generation and function of B cells in the presence of a monoclonal anti-IgM antibody: implications for B cell tolerance.
    Gause A; Yoshida N; Kappen C; Rajewsky K
    Eur J Immunol; 1987 Jul; 17(7):981-90. PubMed ID: 3497044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.
    Mongini PK; Blessinger C; Posnett DN; Rudich SM
    J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyclonal activation of the murine immune system by an antibody to IgD. XI. Contribution of membrane IgD cross-linking to the generation of an in vivo polyclonal antibody response.
    Goroff DK; Holmes JM; Bazin H; Nisol F; Finkelman FD
    J Immunol; 1991 Jan; 146(1):18-25. PubMed ID: 1984444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas.
    Hasbold J; Klaus GG
    Eur J Immunol; 1990 Aug; 20(8):1685-90. PubMed ID: 2209683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of a monoclonal anti-mu chain antiserum on the in vitro growth of normal B cells.
    Boyd AW; Pike BL
    Eur J Immunol; 1982 Mar; 12(3):184-8. PubMed ID: 6807696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells.
    Pennell CA; Scott DW
    Eur J Immunol; 1986 Dec; 16(12):1577-81. PubMed ID: 3493148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
    Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
    Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of cell morphology in B lymphocytes by IL-4: evidence for induced cytoskeletal changes.
    Davey EJ; Thyberg J; Conrad DH; Severinson E
    J Immunol; 1998 Jun; 160(11):5366-73. PubMed ID: 9605136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disparate functions of I-A and I-E molecules on B cells as evidenced by the inhibition with anti-I-A and anti-I-E antibodies of polyclonal B cell activation.
    Takahama Y; Ono S; Ishihara K; Muramatsu M; Hamaoka T
    Eur J Immunol; 1989 Dec; 19(12):2227-35. PubMed ID: 2558020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-Cell suppression in adult mice injected with anti-delta followed by anti-mu mAb.
    Chentoufi AA; Nizet Y; Havaux X; Nisol F; Bazin H; Latinne D
    Cell Immunol; 2000 Oct; 205(1):40-51. PubMed ID: 11078606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
    Goroff DK; Finkelman FD
    J Immunol; 1988 May; 140(9):2919-24. PubMed ID: 2966202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of rat B cell differentiation in vivo by the administration of an anti-mu monoclonal antibody.
    Soares M; Havaux X; Nisol F; Bazin H; Latinne D
    J Immunol; 1996 Jan; 156(1):108-18. PubMed ID: 8598450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.